EpicGenetics and Massachusetts General Hospital (MGH) are launching a Phase II clinical trial to test a tuberculosis vaccine, BCG, as a potential treatment for fibromyalgia. Bruce Gillis, chief executive officer of EpicGenetics Fibromyalgia is a condition marked by widespread pain and sensitivity to touch. For quite some time, many physicians and the general public viewed it as a made-up disorder of neurotic housewives, partly because it was only diagnosed via symptoms and because it affects far more women than men. For physicians who believed in the disorder, diagnosing it was largely a…
Read MoreDay: January 10, 2025
9 Diseases That Can Mimic Fibromyalgia (and Delay Your Diagnosis)
While no one knows what exactly causes fibromyalgia, doctors do know a few things about the condition: The widespread chronic pain disorder seems to involve the nervous system; affects 2 to 4 percent of Americans, mostly women; and commonly occurs in people who have other types of musculoskeletal pain, such as different kinds of arthritis. But unlike many musculoskeletal conditions, fibromyalgia isn’t an inflammatory or autoimmune disease — when your immune system, which normally protects your body from infection, turns against itself and attacks your own cells and tissues. That…
Read More